A preliminary study of the immunohistochemical detection of a Novel tumour marker, 22-1-1 Antigen, in Gynaecological cancer specimens

Annals of the Academy of Medicine Singapore

Volumn 28, Issue 3, 1999, Pages 392-394

  Razvi, K ^a   Sonoda, K ^b   Lee, Y S ^b   Tham, K F ^b   Lim, F K ^b   Yong, E L ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NONE

Author keywords

Adenocarcinoma; Immunohistochemistry; Monoclonal antibody; Squamous cell carcinoma

Indexed keywords

22 1 1 ANTIGEN; 22-1-1 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; COMPARATIVE STUDY; CYSTADENOCARCINOMA; ENDOMETRIUM; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; UTERINE CERVIX;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; CARCINOMA, ADENOSQUAMOUS; CERVIX UTERI; CYSTADENOCARCINOMA, MUCINOUS; ENDOMETRIUM; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033126105     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gupta M K, Arciaga R, Bocci L, Tubbs R, Bukowski R, Deodhar S D. Measurement of a monoclonal-antibody-defined antigen (CA 19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen. Cancer 1985; 56:277-83.
2. Devine P L, McGuckin M A, Ramm L E, Ward B G, Pee D, Long S. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon and prostate. A blind trial with 420 patients. Cancer 1993; 72:2007-15.
3. Solter D, Knowles B B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 1978; 75:5565-9.
4. Itai S, Arii S, Tobe R, Kitahara A, Kim Y C, Yamabe H, et al. Significance of 2-3 and 2-6 sialyl Lewis A antigen in pancreas cancer. Cancer 1988; 61:775-87.
5. Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nakano H, et al. Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995; 6:1099-104.
6. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996; 77:1501-9.
7. Hsu S, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75:816-21.
8. McGee J O, Woods J C, Ashall F, Bramwell M E, Harris H. New marker for human cancer cells. Immunohistochemic detection of the Ca antigen in human tissues with the Ca 1 antigen. Lancet 1982; 2:7-10.
9. Thor A, Viglione M J, Murano R, Ohuchi N, Schlom I, Goldstein F. Monoclonal antibody B72.3 reactivity with human endometruim: a study of normal and malignant tissues. Int J Gynecol Pathol 1987; 6:235-47.
10. Breitenecker G, Neunteufel W, Bieglmayer C, Kolbl H, Schieder K. Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumours. Int J Gynecol Pathol 1989; 8:97-102.
11. Schwartz P E, Chambers S K, Chambers J T, Gutmann J, Katopodis N, Foemmel R. Circulating tumor markers in the monitoring of gynecologic malignancies. Cancer 1987; 60:353-61.